17th Apr 2013 17:16
Notification of Transactions of Directors, Persons Discharging
Managerial Responsibility or Connected Persons
The Administrators of the GlaxoSmithKline UK and US Performance Share Plans notified the Company and the under-mentioned persons on 17 April 2013 of the following increases in their notional interests in Ordinary Shares at a price of 1565.50 pence per Ordinary Share and American Depositary Shares (ADSs) at a price of $48.52 per ADS following the notional re-investment of the dividend paid to shareholders on 11 April 2013.
Ordinary Shares | ADSs | |
Sir Andrew Witty | 14,975.978 | |
Dr M M Slaoui | 4,845.673 | |
Mr S Dingemans | 5,490.762 | |
Mr S M Bicknell | 1,624.186 | |
Mr R G Connor | 325.598 | |
Mrs D P Connelly | 2,058.731 | |
Mr S A Hussain | 4,136.092 | |
Mr W C Louv | 1,408.343 | |
Mr D S Redfern | 2,276.538 | |
Ms C Thomas | 3,143.972 | |
Mr P C Thomson | 800.315 | |
Mr D E Troy | 2,603.915 | |
Dr P J T Vallance | 4,589.736 | |
Ms E Walmsley | 2,596.317 | |
Mr C Weber | 488.564 | |
Mrs V A Whyte | 353.160 |
The notional dividends accrued will be paid out in proportion to the percentage of participants' Performance Share Plan holdings that vest following the end of the relevant three year measurement period.
This notification relates to transactions notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).
V A Whyte
Company Secretary
17 April 2013
Related Shares:
Glaxosmithkline